4.8 Article

Neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice

Journal

SCIENCE
Volume 318, Issue 5847, Pages 71-76

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1146221

Keywords

-

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NIMH NIH HHS [R01 MH081164, R37 MH052804, K08 MH065975, K08 MH065975-04, R37 MH52804-08, K08 MH065975-05] Funding Source: Medline
  3. Autism Speaks [AS1264] Funding Source: Medline

Ask authors/readers for more resources

Autism spectrum disorders (ASDs) are characterized by impairments in social behaviors that are sometimes coupled to specialized cognitive abilities. A small percentage of ASD patients carry mutations in genes encoding neuroligins, which are postsynaptic cell-adhesion molecules. We introduced one of these mutations into mice: the Arg(451)-> Cys(451) (R451C) substitution in neuroligin-3. R451C mutant mice showed impaired social interactions but enhanced spatial learning abilities. Unexpectedly, these behavioral changes were accompanied by an increase in inhibitory synaptic transmission with no apparent effect on excitatory synapses. Deletion of neuroligin-3, in contrast, did not cause such changes, indicating that the R451C substitution represents a gain-of-function mutation. These data suggest that increased inhibitory synaptic transmission may contribute to human ASDs and that the R451C knockin mice may be a useful model for studying autism-related behaviors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available